Overview

Treatment of Pathological Gambling With Naltrexone Pharmacotherapy and Brief Intervention

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this research is to explore the efficacy of the opiate antagonist, naltrexone as combined with CBT-intervention in the treatment of pathological gambling (PG). The study period is 2011-2014 during which one hundred Pathological Gamblers will be recruited to participate to this placebo-controlled double-blind trial.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Finnish Institute for Health and Welfare
National Institute for Health and Welfare, Finland
Treatments:
Naltrexone
Criteria
Inclusion Criteria:

- pathological gambling (scores 5+ from SOGS-R and DSM-IV criteria)

Exclusion Criteria:

- acute hepatitis

- severe liver or kidney dysfunction

- suicide risk or severe depression or other untreated mental health problem

- participation to other gambling research at the same time

- the use of drugs (especially opiates)

- pregnancy

- prisoners

- retarded and mentally ill patients were also excluded